Guadalupe-Elide Morales-Figueroa

Guadalupe-Elide Morales-Figueroa

Auto-generated profile, based on publicly available information

Guadalupe-Elide Morales-Figueroa

Centro de Investigación y de Estudios Avanzados del IPN

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
GNGustavo Nieto-Alamilla
Gustavo Nieto-Alamilla
RMRicardo Márquez-Gómez
Ricardo Márquez-Gómez
AGAna-Maricela García-Gálvez
Ana-Maricela García-Gálvez
GMGuadalupe-Elide Morales-Figueroa
Guadalupe-Elide Morales-Figueroa
JAJose-Antonio Arias-Montaño
Jose-Antonio Arias-Montaño
![Figure][1] Among the four G protein–coupled receptors (H1–H4) identified as mediators of the biologic effects of histamine, the H3 receptor (H3R) is distinguished for its almost exclusive expression in the nervous system and the large variety of isoforms generated by alternative splicing of the corresponding mRNA. Additionally, it exhibits dual functionality as autoreceptor and heteroreceptor, and this enables H3Rs to modulate the histaminergic and other neurotransmitter systems. The cloning of the H3R cDNA in 1999 by Lovenberg et al. allowed for detailed studies of its molecular aspects. In this work, we review the characteristics of the H3R, namely, its structure, constitutive activity, isoforms, signal transduction pathways, regional differences in expression and localization, selective agonists, antagonists and inverse agonists, dimerization with other neurotransmitter receptors, and the main presynaptic and postsynaptic effects resulting from its activation. The H3R has attracted interest as a potential drug target for the treatment of several important neurologic and psychiatric disorders, such as Alzheimer and Parkinson diseases, Gilles de la Tourette syndrome, and addiction. [1]: pending:yes

18 December 2018 in Purinergic Signalling
Verified
Journal Article
Closed access
PDF file
GMGuadalupe-Elide Morales-Figueroa
Guadalupe-Elide Morales-Figueroa
NRNayeli Rivera-Ramírez
Nayeli Rivera-Ramírez
RGRaúl González-Pantoja
Raúl González-Pantoja
JEJuan Escamilla-Sánchez
Juan Escamilla-Sánchez
UGUbaldo García-Hernández
Ubaldo García-Hernández
JAJose-Antonio Arias-Montaño
Jose-Antonio Arias-Montaño

2 June 2014 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
GMGuadalupe-Elide Morales-Figueroa
Guadalupe-Elide Morales-Figueroa
RMRicardo Márquez-Gómez
Ricardo Márquez-Gómez
RGRaúl González-Pantoja
Raúl González-Pantoja
JEJuan Escamilla-Sánchez
Juan Escamilla-Sánchez
JAJose-Antonio Arias-Montaño
Jose-Antonio Arias-Montaño

8 November 2016
Verified
Book Chapter
Closed access
PDF file
RMRicardo Márquez-Gómez
Ricardo Márquez-Gómez
AGAna-Maricela García-Gálvez
Ana-Maricela García-Gálvez
GMGuadalupe-Elide Morales-Figueroa
Guadalupe-Elide Morales-Figueroa
JAJose-Antonio Arias-Montaño
Jose-Antonio Arias-Montaño